PERISCOPE
DEAD

Serial Number

97907734

Owner

ETIOME, INC.

Attorney

Christina M. Licursi

Filing Date

Apr 26, 2023

Add to watchlist:

No watchlists yet
View on USPTO

PERISCOPE Trademark

Serial Number: 97907734

PERISCOPE is a trademark filed by ETIOME, INC. on April 26, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ETIOME, INC. (8 trademarks)

55 CAMBRIDGE PARKWAY
CAMBRIDGE, MA 02142

Entity Type: 03

Flagship Labs 84, Inc. (8 trademarks)

55 Cambridge Parkway, Suite 800E
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

April 26, 2023

Registration Date

Not Registered

Published for Opposition

November 5, 2024

Goods & Services

Pharmaceutical and therapeutic preparations for medical purposes for the treatment of cancer and hematological diseases and disorders, immune system-related diseases and disorders, endocrinological diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, neurodegenerative diseases and disorders, cardiac diseases and disorders, infectious diseases and disorders, skin and hair diseases and disorders, ear or nose or throat diseases and disorders, ocular diseases and disorders, sensory diseases and disorders, orthopedic diseases and disorders, respiratory diseases and disorders, gastrointestinal diseases and disorders, and fungal diseases and disorders

Providing online, non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for data analysis in the fields of healthcare, wellness, system dysregulation, disease, biomedical, and genomic research; Providing online, non-downloadable software featuring artificial intelligence, computational methods, and machine learning models for the design and characterization of biologic therapeutic products and drug analysis in drug discovery and development; scientific research, namely, scientific research and analysis in the field of design and characterization of biologic therapeutic products

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 25, 2026 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 25, 2026 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 18, 2025 EXRA
SOU EXTENSION 1 GRANTED
Oct 17, 2025 EX1G
SOU EXTENSION 1 FILED
Oct 17, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 17, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 22, 2025 NOAM
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Mar 16, 2025 ETOP
POST PUBLICATION AMENDMENT - ENTERED
Feb 3, 2025 CHPB
ASSIGNED TO PETITION STAFF
Feb 3, 2025 APET
TEAS POST PUBLICATION AMENDMENT RECEIVED
Dec 31, 2024 EPPA
EXTENSION OF TIME TO OPPOSE RECEIVED
Nov 25, 2024 ETOF
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 5, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 5, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 16, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 20, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 17, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 17, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 17, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Aug 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Aug 8, 2024 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Aug 1, 2024 ZZZX
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jul 26, 2024 ASGN
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jun 18, 2024 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 3, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
May 31, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 31, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
May 31, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 7, 2024 GNFN
FINAL REFUSAL E-MAILED
May 7, 2024 GNFR
FINAL REFUSAL WRITTEN
May 7, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 30, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 30, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 30, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 31, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jan 31, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jan 31, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 24, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 24, 2023 NWOS